Prestige Consumer Healthcare PBH Other OTC — Total revenues

Other product segments

Similar metrics at other companies

BLCOOTC — Total revenues

$444M+8.6%

SUPNOther — Total revenues

$4.67M-45.6%

ICEOT Cand Other Transactions — Total revenues

$102M-1.0%

DUOLOther — Total revenues

$682K+52.9%

BLCOOther revenues — Total revenues

$5M+25.0%

RNGOther — Total revenues

$21.03M-4.2%

Questions, answered.

What is Prestige Consumer Healthcare's other OTC — total revenues?

Prestige Consumer Healthcare (PBH) reported other OTC — total revenues of $5.35M in Q1 2026.

How has Prestige Consumer Healthcare's other OTC — total revenues changed year-over-year?

Prestige Consumer Healthcare's other OTC — total revenues increased by 39.2% year-over-year, from $3.85M to $5.35M.

What is the long-term trend for Prestige Consumer Healthcare's other OTC — total revenues?

Over 4 years (2022 to 2026), Prestige Consumer Healthcare's other OTC — total revenues has grown at a 11.4% compound annual growth rate (CAGR), from $9.99M to $15.39M.

What does other OTC — total revenues mean?

This metric represents the total gross revenue generated by the company's miscellaneous over-the-counter healthcare product lines that fall outside of its primary core brand categories. It reflects the market demand and commercial performance of these secondary niche health products within the consumer healthcare portfolio. Tracking this revenue stream helps investors assess the contribution of smaller, non-core assets to the overall top-line growth of the business.